agilon health Inc. has entered into a Third Amendment to its existing Credit Agreement, originally dated February 18, 2021, with J.P. Morgan Chase Bank, N.A. and other lenders. The amendment extends the maturity date of the credit facility from February 18, 2026, to February 18, 2028, and introduces several changes to the agreement's terms. These include measuring certain covenant baskets as a percentage of EBITDA, requiring agilon health management to maintain a minimum of $50 million in total cash daily, and conditioning certain payments to its holding company on achieving positive EBITDA for two consecutive four-quarter periods. The amendment also reduces the revolving credit commitments from $100 million to $90 million and requires cash collateralization of letters of credit at 103% of their value. Additionally, agilon health Inc. has provided an unsecured guaranty of its subsidiary’s obligations under the amended credit facility.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. agilon health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-007671), on February 12, 2026, and is solely responsible for the information contained therein.